Generics 28

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Travoprost manufacturers

28 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

28 products found

travoprost

Eye drops 0.004 % - 2.5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #35915

Established in 2007, this family-owned manufacturer specializes in pharmaceutical formulations, offering over 500 products across various dosage forms, including tablets, capsules, dry syrups, ointments, dry injections, and liquid orals. As a CTD dossier owner and manufacturer, it holds WHO-cGMP certification, ensuring compliance with stringent international quality standards. The manufacturer operates advanced production lines with capacities such as 3,600 million tablets, 1,800 million capsules, 240 million liquid injections in ampoules, and 70 million dry powder injections per annum, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 7 days

travoprost

Eye drops 0.004 % w/v

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18647
This pharmaceutical company offers a wide range of products, including prescription and over-the-counter medications across various therapeutic areas such as analgesics, antibiotics, anti-infectives, cold and allergy remedies. They also produce nutraceuticals and Ayurvedic medicines. The company emphasizes quality assurance, using high-grade ingredients sourced from reliable vendors and adhering to GMP certifications. While specific product patents are not mentioned, they highlight a focus on value-added products for patient benefit. The company appears to operate primarily in the EU and North America, with production facilities dedicated to both Ayurvedic-herbal food supplements and allopathic medications.

travoprost

Eye drops 40µg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18331
This pharmaceutical company specializes in manufacturing a wide range of dosage forms including capsules, tablets, dry injections, oral solutions, and liquid injectables. They appear to have a strong focus on respiratory medications, pain management products (like those containing piroxicam), and gastrointestinal treatments. The company boasts multiple production facilities and is actively pursuing certifications like FDA, NMA, MHRA, and Russian Federation approvals, indicating a commitment to global markets. They emphasize their quality standards and are dedicated to research and development. While they primarily export products, their website mentions offering contract manufacturing services.

Want to see all 28 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Travoprost

Travoprost treats high pressure inside the eye including glaucoma, specifically used for open-angle glaucoma when other agents are not sufficient. It is an eye drop which shows effects generally within two hours. Its actions lower high pressure inside the eye which helps in preventing blindness. Travoprost regulates the flow of fluid in the eye thus helping to maintain a normal pressure. Travoprost is sold under the brand name Travatan among others. Kabi Pharmacia Ab first file patent or the process to make Travoprost in 1991. It was later approved for sales in the USA and EU in 2001. In 2017, it was prescribed to more than two million patients and is now sold as a generic medication in the United Kingdom.

Dosage and administration

Travoprost is sold as a sterile Ophthalmic Solution 0.004%, for Topical Ophthalmic Use. Travoprost dosage is recommended at one drop in the affected eye once a day in the evening. It should not be administered more than once a day as frequent administration of prostaglandin analogs can reduce the intraocular pressure lowering effect. The medicine starts reducing the intraocular pressure approximately 2 hours after the first administration and the effect can up to 12 hours. It can also be used concomitantly with other topical ophthalmic medicines in lowering intraocular pressure. But while being used in combination with other drugs, they should be administered at least 5 minutes apart.

The price of Travoprost

In the USA, the average retail price of a generic eye dropper with 2.5ml of 0.0004% strength is sold or around $164.84. In India, the same supply of 2.5ml of one dropper cost around USD 8.5.

How does Travoprost work?

Travoprost is a synthetic prostaglandin analog or more specifically, an analog of prostaglandin F2α. Its actions increase the outflow of aqueous fluid from the eyes. Like other medicines of the same class, like tafluprost and latanoprost, Travoprost is an ester prodrug of the free acid. These actions make it an agonist at the prostaglandin F receptor. This helps to increase the outflow of aqueous fluid from the eye. The eventual result of this the outflow is the lowering of the intraocular pressure.

Finding Travoprost Manufacturers and Suppliers:

The process of finding trusted Travoprost manufacturers and Travoprost suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. In addition, it is easy to use an online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Travoprost. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.